P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).

Scott M. Schuetze,Karla V. Ballman,Kristen N. Ganjoo,Elizabeth J. Davis,Jeffrey A. Morgan,Gabriel Tinoco,Melissa Amber Burgess,Brian A. Van Tine,Edwin Choy,Dale R. Shepard,Ciara Marie Kelly,Richard F. Riedel,Margaret von Mehren,Brittany L. Siontis,Steven Attia,Gary K. Schwartz,Hari Anant Deshpande,Erin Kozlowski,Helen X. Chen,Brian P. Rubin

P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).

2021

11503Background: EHE is a rare vascular cancer arising in liver, lung, soft tissue and bone. The natural history of metastatic disease varies considerably from indolent growth over years to rapid g...

Keywords:

Epithelioid hemangioendothelioma
Trametinib
in patient
Cancer
Medicine
Lung
Soft tissue
Natural history
Disease
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations